Search results for "Complement"

showing 10 items of 2113 documents

Disulfide bridge formation between C1q and IgG in vitro.

1990

The globular heads of C1q are known to possess free-SH groups. Here we show that these groups, which are concealed in the native molecule, are exposed by interaction of C1q with dialysis membrane. During iodination, I+ and I2 oxidize these sulfhydryls to produce disulfide-linked C1q aggregates. Approximately 15% of C1q bound to immunoglobulin aggregates is resistant to high conductivity elution and reducing agent is required to release it. These data show that dialysis, adsorption to Ig and iodination of C1q result in structural and functional changes in the molecule, and suggest a mechanism by which these changes occur. Disulfide bridging between C1q and IgG in vitro suggests that this may…

MaleReducing agentImmunologyGuinea Pigschemical and pharmacologic phenomenaBiologyIn Vitro Techniquesurologic and male genital diseasesDialysis tubingfluids and secretionsimmune system diseasesImmunology and AllergyAnimalsSulfhydryl Compoundsskin and connective tissue diseasesComplement C1qComplement ActivationGel electrophoresisComplement C1qIn vitroBiochemistryImmunoglobulin Gbiology.proteinElectrophoresis Polyacrylamide GelFemaleAntibodyDialysis (biochemistry)CysteineEuropean journal of immunology
researchProduct

Novel sequential stress model for functional dyspepsia: Efficacy of the herbal preparation STW5

2015

Abstract Background Many screening procedures for agents with potential usefulness in functional dyspepsia (FD) rely on animals exposed to stress early in life (neonatal maternal separation, NMS) or in adulthood (restraint stress, RS). Purpose Since many clinical cases of FD have been associated with stress in early life followed by stress in adulthood, a sequential model simulating the clinical situation is described. To explore the validity of the model, the efficacy of STW5, a multicomponent herbal preparation of proven usefulness in FD, was tested. Study design/methods A sequential stress model established where rats are exposed to NMS after birth followed later by RS in adulthood. Stre…

MaleRestraint PhysicalDrugFunctional dyspepsiaPathologymedicine.medical_specialtyCorticotropin-Releasing Hormonemedia_common.quotation_subjectPharmaceutical SciencePharmacologySTW5chemistry.chemical_compoundCorticosteroneDrug DiscoverymedicineAnimalsNeonatal maternal separationDyspepsiaRats WistarScreening proceduresmedia_commonPharmacologyRestraint stressPlant Extractsbusiness.industryMaternal DeprivationGastric accommodationPlasma levelsGhrelinRatsDisease Models AnimalchemistryComplementary and alternative medicineMolecular MedicineFemaleGhrelinAnalysis of varianceRestraint stressCorticosteroneGastrointestinal MotilitybusinessStress PsychologicalHormonePhytomedicine
researchProduct

C1-Esterase-Inhibitor Treatment at Early Reperfusion of Hemorrhagic Shock Reduces Mesentery Leukocyte Adhesion and Rolling

2001

Objective: Complement activation probably plays a pathogenic role in multiple organ failure in shock. This study evaluates the effects of C1-esterase-inhibitor treatment on leukocyte-endothelial interaction in the mesenteric microcirculation in hemorrhagic shock. Methods: Rats underwent median laparotomy and exteriorization of an ileal loop for intravital microscopy of the mesenteric microcirculation. Volume controlled hemorrhagic shock was provoked by arterial blood withdrawal (2.5 mL/ 100 g body wt. for 60 minutes) followed by a 4-hour reperfusion period. C1-INH (100 IU/kg body wt. i.v.) or 0.9% NaCl i.v. were administered as a bolus at the beginning of reperfusion. Reperfusion time mimic…

MaleResuscitationPhysiologymedicine.medical_treatmentComplement C1 Inactivator ProteinsShock HemorrhagicMicrocirculationRats Sprague-DawleyComplement inhibitorBolus (medicine)IleumPhysiology (medical)Cell AdhesionLeukocytesmedicineAnimalsSplanchnic CirculationMolecular BiologySalinebusiness.industryMicrocirculationHemodynamicsRatsComplement systemChemotaxis LeukocyteKineticsAnesthesiaReperfusionArterial bloodEndothelium VascularCardiology and Cardiovascular MedicinebusinessIntravital microscopyMicrocirculation
researchProduct

Evidence that C1q, a Subcomponent of the First Component of Complement, is an Fc Receptor of Peritoneal and Alveolar Macrophages

1980

Abstract Guinea pig peritoneal macrophages were cultured for 24 h in the presence of two inhibitors of the biosynthesis of collagen-like molecules such as C1q : 10 -3 M 3,4-dehydroproline or 10 -4 M 2,2′-dipyridyl. Their Fc-receptor activity was measured by rosette formation, using sheep erythrocytes (E) coated with rabbit anti-sheep IgG (EA IgG ). The Fc-receptor activity was decreased by 40 to 70% of control cultures depending on the amount of IgG on the E. The activity of a second receptor on the macrophages, mediating the binding of C3b coated E, was not altered by this treatment. Rat alveolar macrophages were depleted of their Fc-receptor activity by pronase treatment (1.5 mg/ml) in th…

MaleRosette FormationProlineGuinea PigsImmunologyFc receptorReceptors FcPronaseGuinea pigchemistry.chemical_compound22'-DipyridylBiosynthesisComplement C1AnimalsAscitic FluidImmunology and AllergySecretionReceptorIncubationbiologyMacrophagesComplement C3HematologyMolecular biologyRatsReceptors ComplementPulmonary AlveoliMembraneBiochemistrychemistryPronasebiology.proteinFemaleImmunobiology
researchProduct

Linking C5 deficiency to an exonic splicing enhancer mutation

2005

Abstract As an important component of the innate immune system, complement provides the initial response to prevent infections by pathogenic microorganisms. Patients with dysfunction of C5 display a propensity for severe recurrent infections. In this study, we present a patient with C5 deficiency demonstrated by immunochemical and functional analyses. Direct sequencing of all C5 exons displayed no mutation of obvious functional significance, except for an A to G transition in exon 10 predicting an exchange from lysine to arginine. This sequence alteration was present in only one allele of family members with a reduced serum C5 concentration and in both alleles of the patient with almost com…

MaleSequence analysisDNA Mutational AnalysisImmunologyExonic splicing enhancerBiologymedicine.disease_causeExonmedicineHumansImmunology and AllergyGeneFamily HealthGeneticsMutationSplice site mutationComplement C5ExonsSequence Analysis DNAC5 DeficiencyMolecular biologyAlternative SplicingPhenotypeChild PreschoolMutationRNA splicingThe Journal of Immunology
researchProduct

Two‐dimensional analysis of myocardial protein expression following myocardial ischemia and reperfusion in rabbits

2002

Myocardial ischemia and reperfusion injury (MI/R) can be related to leukocyte activation with subsequent release of cytokines and oxygen derived free radicals. Activation of the complement system has been implicated in the pathogenesis of myocardial ischemia and reperfusion injury. Inflammatory injury will subsequently result in cellular activation and protein synthesis. In the present study we analyzed the myocardial protein expression and its pattern following myocardial ischemia and reperfusion, with and without complement inhibition with the synthetic serine protease inhibitor Futhan/nafamstat mesilate (FUT-175) known to inhibit classical and alternative complement pathway in a rabbit m…

MaleSerine Proteinase InhibitorsNecrosisProteomeNeutrophilsMyocardial IschemiaIschemiaMyocardial Reperfusion InjuryPharmacologyGuanidinesBiochemistrySuperoxide dismutaseNecrosisRandom AllocationComplement inhibitormedicineAnimalsElectrophoresis Gel Two-DimensionalCreatine KinaseMolecular BiologybiologySuperoxide DismutaseChemistryGene Expression ProfilingMyocardiumHemodynamicsProteinsalpha-Crystallin B Chainmedicine.diseaseBenzamidinesComplement systemBiochemistrybiology.proteinAlternative complement pathwayCreatine kinaseRabbitsmedicine.symptomReperfusion injuryPROTEOMICS
researchProduct

An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase

1991

AbstractTo gain an understanding of the mechanism by which the subcellular distribution of cytosolic epoxide hydrolase (cEH) is directed, we have analyzed the carboxy terminal region of rat liver cEH by means of cDNA cloning to define the structure of its possible peroxisomal targeting sequence (PTS). Purified cEH was subjected to peptide analysis following endoproteinase Glu-C digestion and HPLC-separation of the fragments. The obtained sequence information was used to perform PCR experiments resulting in the isolation of a 680 bp cDNA clone encoding the carboxy terminus of cEH. The deduced amino acid sequence displays a terminal tripeptide Ser-Lys-Ile which is highly homologous to the PTS…

MaleSignal peptidePTSanimal structures1303 BiochemistryMolecular Sequence DataBiophysics10050 Institute of Pharmacology and Toxicology610 Medicine & healthTripeptideProtein Sorting SignalsBiologyMicrobodiesBiochemistryAmino acid sequence1307 Cell BiologyCytosol1315 Structural Biology1311 GeneticsStructural BiologyComplementary DNAGenetics1312 Molecular BiologyAnimalsCloning MolecularEpoxide hydrolaseMolecular BiologyPeptide sequenceEpoxide Hydrolaseschemistry.chemical_classificationBase SequencecDNA sequenceDNACell BiologyPeroxisomeMolecular biologyRatsIsoenzymesCytosolPCREnzymeLiverchemistryBiochemistrycEH570 Life sciences; biologyPeptide analysis1304 Biophysics
researchProduct

Sequence of a novel cytochrome CYP2B cDNA coding for a protein which is expressed in a sebaceous gland, but not in the liver

1992

The major phenobarbital-inducible rat hepatic cytochromes P-450, CYP2B1 and CYP2B2, are the paradigmatic members of a cytochrome P-450 gene subfamily that contains at least seven additional members. Specific oligonucleotide probes for these genomic members of the CYP2B subfamily were used to assess their tissue-specific expression. In Northern-blot analysis a probe specific to gene 4 (which is designated now as CYP2B12) hybridized to a single mRNA present in the preputial gland, an organ which is used as a model for sebaceous glands, but did not hybridize to mRNA isolated from the liver or from five other tissues of untreated or Aroclor 1254-treated rats. The cDNA sequence for the CYP2B12 R…

MaleSubfamily1303 BiochemistryMolecular Sequence Data10050 Institute of Pharmacology and Toxicology610 Medicine & healthBiologyBiochemistryRats Sprague-Dawley1307 Cell BiologySebaceous GlandsRapid amplification of cDNA endsCytochrome P-450 Enzyme SystemComplementary DNAMicrosomes1312 Molecular BiologyCoding regionAnimalsAmino Acid SequenceMolecular BiologyBase SequencecDNA librarySingle-Strand Specific DNA and RNA EndonucleasesProtein primary structureNucleic acid sequenceCell BiologyDNARibonuclease PancreaticBlotting NorthernMolecular biologyRatsOpen reading frameBiochemistryLiverMultigene FamilyMicrosomes Liver570 Life sciences; biologyFemaleOligonucleotide ProbesResearch Article
researchProduct

hDAF expression in hearts of transgenic pigs obtained by sperm-mediated gene transfer.

2000

TRANSPLANTATON has been the choice option to treat successfully an increasing number of acute and chronic human pathologies with declining morbidity and mortality. However, availability of organs from human donors is limited and dramatically inadequate with respect to patient requests. Xenotransplantation from large-sized mammals has thus been reconsidered as a tool to overcome the present unbalance between organ offers and requests. Pigs have been chosen because they can be easily and cheaply bred; they do not raise ethical questions—their use as alimentary resources is generally admitted; and they possess organs largely human compatible for size, anatomical organization, and physiology. N…

MaleSwineTransgeneXenotransplantationmedicine.medical_treatmentTransplantation HeterologousBiologyAnimals Genetically ModifiedSperm-mediated gene transferDAF;transgenic;xenotransplantationAntigens CDxenotransplantationmedicineAnimalsHumansDecay-accelerating factortransgenicGeneticsTransplantationCD55 AntigensDAFMyocardiumGenetic transferGene Transfer TechniquesImmunohistochemistrySpermatozoaComplement systemCell biologyGenetically modified organismTransgenesisSurgeryTransplantation proceedings
researchProduct

Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer

2013

[EN] Background There is a medical need for diagnostic biomarkers in lung cancer. We evaluated the diagnostic performance of complement activation fragments. Methods We assessed complement activation in four bronchial epithelial and seven lung cancer cell lines. C4d, a degradation product of complement activation, was determined in 90 primary lung tumors; bronchoalveolar lavage supernatants from patients with lung cancer (n = 50) and nonmalignant respiratory diseases (n = 22); and plasma samples from advanced (n = 50) and early lung cancer patients (n = 84) subjects with inflammatory lung diseases (n = 133), and asymptomatic individuals enrolled in a lung cancer computed tomography screenin…

MaleSystemCancer ResearchConferLung NeoplasmsExpression0302 clinical medicineDiagnosisComplement ActivationEarly Detection of CancerInhibition0303 health scienceseducation.field_of_studyrespiratory systemComplement C4bMiddle AgedPrognosis3. Good healthOncology030220 oncology & carcinogenesisFemaleLung cancerBronchoalveolar Lavage FluidC1QAdultCellsPopulationBiologyArticle03 medical and health sciencesClassical complement pathwayImmune systemPredictive Value of TestsFactor-hmedicineBiomarkers TumorComplement C4bHumansComplement Pathway ClassicalLung cancereducation030304 developmental biologyAgedNeoplasm StagingImmune-responseCancerMICROBIOLOGIAmedicine.diseasePeptide FragmentsComplement systemImmunologyNational Lung Screening TrialPathwayJNCI Journal of the National Cancer Institute
researchProduct